0001103021-19-000006.txt : 20190815
0001103021-19-000006.hdr.sgml : 20190815
20190815162527
ACCESSION NUMBER: 0001103021-19-000006
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190813
FILED AS OF DATE: 20190815
DATE AS OF CHANGE: 20190815
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Greenleaf Peter
CENTRAL INDEX KEY: 0001363683
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31361
FILM NUMBER: 191030575
MAIL ADDRESS:
STREET 1: ONE MEDIMMUNE WAY
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIODELIVERY SCIENCES INTERNATIONAL INC
CENTRAL INDEX KEY: 0001103021
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 352089858
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4131 PARKLAKE AVENUE
STREET 2: SUITE 225
CITY: RALEIGH
STATE: NC
ZIP: 27612
BUSINESS PHONE: 919 582 9050
MAIL ADDRESS:
STREET 1: 4131 PARKLAKE AVENUE
STREET 2: SUITE 225
CITY: RALEIGH
STATE: NC
ZIP: 27612
FORMER COMPANY:
FORMER CONFORMED NAME: MAS ACQUISITION XXIII CORP
DATE OF NAME CHANGE: 20000111
4
1
wf-form4_156590070881930.xml
FORM 4
X0306
4
2019-08-13
0
0001103021
BIODELIVERY SCIENCES INTERNATIONAL INC
BDSI
0001363683
Greenleaf Peter
C/O BIODELIVERY SCIENCES INTL, INC.,
4131 PARKLAKE AVE. SUITE 225
RALEIGH
NC
27612
1
0
0
0
Common Stock
2019-08-13
4
M
0
21144
0
A
24788
D
Restricted Stock Units
0.0
2019-08-13
4
M
0
21144
0
D
2022-08-01
Common Stock
21144.0
87500
D
The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units ("RSUs") granted to the Reporting Person on August 1, 2018 under the Issuer's 2011 Equity Incentive Plan, as amended. The remaining RSUs under this grant will vest as follows: (i) 35,000 RSUs vest in the first open window following the Company's 2020 Annual Meeting of Stockholders, (ii) 35,000 RSUs vest in the first open window following the Company's 2021 Annual Meeting of Stockholders and (iii) 17,500 RSUs vest in the first open window following the Company's 2022 Annual Meeting of Stockholders.
/s/ Peter Greenleaf
2019-08-15